Taha Muhamed-Kheir, Alonso Jean-Michel, Cafferkey Mary, Caugant Dominique A, Clarke Stuart C, Diggle Mathew A, Fox Andrew, Frosch Matthias, Gray Stephen J, Guiver Malcolm, Heuberger Sigrid, Kalmusova Jitka, Kesanopoulos Konstantinos, Klem Anne-Marie, Kriz Paula, Marsh John, Mölling Paula, Murphy Karen, Olcén Per, Sanou Oumar, Tzanakaki Georgina, Vogel Ulrich
Neisseria Unit and the French National Reference Center for Meningococci, Institut Pasteur, Paris, France.
J Clin Microbiol. 2005 Jan;43(1):144-9. doi: 10.1128/JCM.43.1.144-149.2005.
Twenty clinical samples (18 cerebrospinal fluid samples and 2 articular fluid samples) were sent to 11 meningococcus reference centers located in 11 different countries. Ten of these laboratories are participating in the EU-MenNet program (a European Union-funded program) and are members of the European Monitoring Group on Meningococci. The remaining laboratory was located in Burkina Faso. Neisseria meningitidis was sought by detecting several meningococcus-specific genes (crgA, ctrA, 16S rRNA, and porA). The PCR-based nonculture method for the detection of N. meningitidis gave similar results between participants with a mean sensitivity and specificity of 89.7 and 92.7%, respectively. Most of the laboratories also performed genogrouping assays (siaD and mynB/sacC). The performance of genogrouping was more variable between laboratories, with a mean sensitivity of 72.7%. Genogroup B gave the best correlation between participants, as all laboratories routinely perform this PCR. The results for genogroups A and W135 were less similar between the eight participating laboratories that performed these PCRs.
二十份临床样本(18份脑脊液样本和2份关节液样本)被送往位于11个不同国家的11个脑膜炎球菌参考中心。其中十个实验室参与了欧盟脑膜炎球菌监测网络项目(一个由欧盟资助的项目),并且是欧洲脑膜炎球菌监测小组的成员。其余的实验室位于布基纳法索。通过检测几个脑膜炎球菌特异性基因(crgA、ctrA、16S rRNA和porA)来查找脑膜炎奈瑟菌。基于聚合酶链反应的非培养法检测脑膜炎奈瑟菌在参与者之间得出了相似的结果,平均灵敏度和特异性分别为89.7%和92.7%。大多数实验室还进行了基因分型检测(siaD和mynB/sacC)。基因分型的检测结果在各实验室之间的差异更大,平均灵敏度为72.7%。B群在参与者之间的相关性最佳,因为所有实验室都常规进行此项聚合酶链反应。进行这些聚合酶链反应的八个参与实验室中,A群和W135群的结果相似度较低。